CWRU, MetroHealth develop targeted therapy for relapsed leukemia

CLEVELAND, Ohio — Researchers at Case Western Reserve University School of Medicine and MetroHealth System have developed a way to target treatment-resistant leukemia cells, offering a potential solution to one of the most persistent challenges in blood cancer therapy. The new approach uses programmable nanoparticles — tiny RNA-based drug carriers that can be programmed to find specific cancer ...